AzTrials
AzTrials

BurnsNCT03924908

Impact of Virtual Reality Hypnosis on Pain and Anxiety During Dressings Change in Burn Patients

A study testing VRH and VR in people with Burns and Pain, Acute, run by University of Liege.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Different non-pharmacological techniques, including hypnosis and virtual reality are currently used as complementary tools in the treatment of pain related to burn injury. A new technique called 'virtual reality hypnosis' (VRH) (Patterson et al., 2004), which encompasses a combination of both tools, is regularly used… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Burns, Pain, Acute, Anxiety
What is being tested?
VRH and VR
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
1 Jan 2023to 1 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Burn patient treated as outpatient
  • Burn surface area > or = 5% of the total body surface area
  • mainly 2nd degree burn

Who cannot join

  • Psychiatric antecedents
  • Claustrophobia
  • Heavy hearing
  • Visual impairment
  • Face burn
  • Conjunctivitis
  • Consent not obtained

About this study

Official title: Impact of Virtual Reality Hypnosis on Pain and Anxiety During Dressings Change in Burn Patients Treated as Outpatients

Different non-pharmacological techniques, including hypnosis and virtual reality are currently used as complementary tools in the treatment of pain related to burn injury. A new technique called 'virtual reality hypnosis' (VRH) (Patterson et al., 2004), which encompasses a combination of both tools, is regularly used although its actual function remains unknown to this date. With the goal to improve our understanding of VRH combination effects, it is necessary to elaborate randomized and controlled research studies in order to understand their actual function in individual's perception. 100 patients who are treated as outpatients for burn care will be randomly assigned to virtual reality or VRH. Patients will receive one session of one of these techniques during burn dressing change.Physiological parameters will be recorded during dressing change. Participants will fill in a questionnaire evaluating their tendency to be absorbed and dissociated, and another evaluating their level of perceived immersion. Their level of anxiety, pain, fatigue and relaxation will be evaluated before and after the session. A short interview will also be conducted to give participants the opportunity to openly describe their experience.

Being tested
VRH, VR
Medical subject headings
Burns, Acute Pain, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VRHBehavioural

    Patients will see a 3D film combined with a hypnotic voice during the entire procedure of dressing change

  • VRBehavioural

    Patients will see a 3D film without any hypnotic voice during the entire procedure of dressing change

Study groups in NCT03924908
Study groupRoleWhat they receive
VRHExperimentalVirtual reality hypnosis
Receives: Behavioral: VRH
VRActive comparatorVirtual reality
Receives: Behavioral: VR

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain perception: Visual Analogical Scale (VAS)

    Visual Analogical Scale (VAS) from 0 to 10. This is a subjective linear scale. No pain = 0, maximum pain = 10.

    Measured: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")

  2. Change in anxiety: Visual Analogical Scale (VAS)

    Visual Analogical Scale (VAS) from 0 to 10. This is a subjective linear scale. No anxiety = 0, maximum anxiety = 10.

    Measured: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")

  3. Change in fatigue

    Visual Analogical Scale (VAS) from 0 to 10. This is a subjective linear scale. No fatigue = 0, maximum fatigue = 10.

    Measured: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")

  4. Change in relaxation level

    Visual Analogical Scale (VAS) from 0 to 10. This is a subjective linear scale. No relaxation = 0, maximum relaxation = 10.

    Measured: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")

Secondary outcomes (4)
  1. Level of absorption at the moment

    Absorption will be measured as the two components of hypnosis. We will measure absorption and dissociation using the Visual Analogical Scales (VAS). VAS is from 0 to 10. 0 is not absorbed and 10 is really absorbed. When responding to a VAS item, participants will be asked to specify their level of agreement to a statement by indicating a position along a continuous line between two end-points.

    Measured: 5 minutes after dressing change ("time 1")

  2. Level of dissociation at the moment

    Dissociation will be measured as the two components of hypnosis. We will measure absorption and dissociation using the Visual Analogical Scales (VAS). When responding to a VAS item, participants will be asked to specify their level of agreement to a statement by indicating a position along a continuous line between two end-points.

    Measured: 5 minutes after dressing change ("time 1")

  3. Time perception

    We will ask to the patient his perception of time during the session.

    Measured: 5 minutes after dressing change ("time 1")

  4. Change in heart rate

    Physiological parameter measured using pulse oximeter

    Measured: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Apr 2019
  2. Study start1 Jan 2023 (estimated)
  3. Primary completion1 Jun 2025 (estimated)
  4. Study completion1 Jun 2025 (estimated)

Why it stopped: Not enough human resources

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03924908
Sponsor's protocol ID
BurnVR-H
Status last verified
Jun 2023
First submitted
11 Apr 2019
Last updated
27 Jun 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VRH and VR in people with Burns and Pain, Acute, run by University of Liege.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 27 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain perception: Visual Analogical Scale (VAS) (time frame: 5 minutes before dressing change ("time 0") and 5 minutes after dressing change ("time 1")). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in